![Theranos and Walgreens Bury the Hatchet—For Now](https://www.g2intelligence.com/wp-content/uploads/2023/04/56181_G2_stock_3-1080x675.jpg)
Theranos and Walgreens Bury the Hatchet—For Now
From - G2 Compliance Advisor
It all looked so promising back in 2015. Privately-held Theranos was poised to usher in a new era of diagnostics with its revolutionary fingerprick technology for…
From - G2 Compliance Advisor
It all looked so promising back in 2015. Privately-held Theranos was poised to usher in a new era of diagnostics with its revolutionary fingerprick technology for…
From - National Intelligence Report
While the strategy of targeting the China market is nothing new, the tactics have evolved. Recognizing the need for a…
From - Laboratory Industry Report
When it comes to measuring Dx product effectiveness, few things speak louder than the attitudes of ordering physicians. With that in mind…
From - Laboratory Industry Report
After a relatively slow March and April, business has picked up noticeably in May, June and July with deal volume increasing across all…
...